<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.37">
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">
<title>SCOPE DCC Analytic Plan - 12&nbsp; Recruitment Methods</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
</style>

<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./27_site.html" rel="next">
<link href="./25_inclusion_exclusion.html" rel="prev">
<link href="./SOM_c_clr.png" rel="icon" type="image/png">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark"><script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script><link href="site_libs/pagedtable-1.1/css/pagedtable.css" rel="stylesheet">
<script src="site_libs/pagedtable-1.1/js/pagedtable.js"></script>
</head>
<body class="nav-sidebar floating nav-fixed">


<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top"><nav class="navbar navbar-expand-lg navbar-dark "><div class="navbar-container container-fluid">
      <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">SCOPE DCC Analytic Plan</span>
  </a>
          <div class="quarto-toggle-container ms-auto">
              <a href="" class="quarto-color-scheme-toggle nav-link" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
              <a href="" class="quarto-reader-toggle nav-link" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
          </div>
          <div id="quarto-search" class="" title="Search"></div>
      </div> <!-- /container-fluid -->
    </nav><nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }"><div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title">
<span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Recruitment Methods</span>
</h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav></header><!-- content --><div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto"><div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        <div class="sidebar-tools-collapse tools-wide">
    <a href="https://github.com/Goodgolden/scope_dcc" title="" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="https://medschool.cuanschutz.edu/health-care-policy-and-research" title="" class="sidebar-tool px-1"><i class="bi bi-info-circle"></i></a>
    <a href="https://coloradosph.cuanschutz.edu/education/departments/biostatistics-informatics" title="" class="sidebar-tool px-1"><i class="bi bi-hospital"></i></a>
</div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Read Me First</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./00_activity_log.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Activity Log</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./00_sap_revisions.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">SAP revisions</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./10_administrative_information.html" class="sidebar-item-text sidebar-link">Administrative Information</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./11_study_information.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Study Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./12_roles_and_responsibilities.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Responsibilities</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./14_project_information.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Project Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./15_investigator_agreement.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Investigator Agreement</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./16_signatures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Signatures</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./20_study_overview.html" class="sidebar-item-text sidebar-link">Study Overview</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./21_background.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Background</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./23_interested_variables.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Preliminary Data</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./25_inclusion_exclusion.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Inclusion Exclusion</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./26_recruitment.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Recruitment Methods</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./27_site.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Multi-Site Research</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./28_timeline.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Timeline</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./29_stopping.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">Study Endpoints</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./22_aims_and_hypotheses.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">Aims and Hypotheses</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./24_causal_dag.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">17</span>&nbsp; <span class="chapter-title">Causal Dag</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./30_study_design.html" class="sidebar-item-text sidebar-link">Study Methods</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./36_randomize.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">18</span>&nbsp; <span class="chapter-title">Randomization</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./37_fidelity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Fidelity of Design</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./38_measures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">20</span>&nbsp; <span class="chapter-title">Study Measures</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./31_sample_size.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">21</span>&nbsp; <span class="chapter-title">Sample Size</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./32_interim_analyses.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">22</span>&nbsp; <span class="chapter-title">Interim Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./33_data.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">23</span>&nbsp; <span class="chapter-title">Data Information</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./34_missing_data.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">24</span>&nbsp; <span class="chapter-title">Missing Data</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./35_subjects.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">25</span>&nbsp; <span class="chapter-title">Subjects</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./39_provisions_safety.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">26</span>&nbsp; <span class="chapter-title">Safety of Subjects</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./40_statistical_analysis.html" class="sidebar-item-text sidebar-link">Statistical Analysis</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./41_descriptive_statistics.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">27</span>&nbsp; <span class="chapter-title">Descriptive Statistics</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./42_analysis_methods.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">28</span>&nbsp; <span class="chapter-title">Analysis Methods</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./43_additional.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">29</span>&nbsp; <span class="chapter-title">Additional Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./43_sensitivity_analysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">30</span>&nbsp; <span class="chapter-title">Sensitivity Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./44_exploratory_analysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">31</span>&nbsp; <span class="chapter-title">Exploratory Analysis</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./47_simulations.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">32</span>&nbsp; <span class="chapter-title">Simulation Study</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./45_software.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">33</span>&nbsp; <span class="chapter-title">Software and Packages</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./46_others.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">34</span>&nbsp; <span class="chapter-title">Other Information</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./50_tables_shells.html" class="sidebar-item-text sidebar-link">Tables Functions</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./51_a_tables.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">35</span>&nbsp; <span class="chapter-title">Tables</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./52_figures.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">36</span>&nbsp; <span class="chapter-title">Figures</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./53_examples.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">37</span>&nbsp; <span class="chapter-title">Example</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a href="./60_additional_information.html" class="sidebar-item-text sidebar-link">Additional Information</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-6" class="collapse list-unstyled sidebar-section depth1 show">
<li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./61_appendices.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">38</span>&nbsp; <span class="chapter-title">Appencies</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./62_glossary.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">39</span>&nbsp; <span class="chapter-title">Glossary</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./63_addenda.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">40</span>&nbsp; <span class="chapter-title">Addenda</span></a>
  </div>
</li>
      </ul>
</li>
        <li class="sidebar-item sidebar-item-section">
      <span class="sidebar-item-text sidebar-link text-start">References</span>
  </li>
    </ul>
</div>
</nav><!-- margin-sidebar --><div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc"><h2 id="toc-title">Table of contents</h2>
   
  <ul>
<li>
<a href="#sec-recruitment" id="toc-sec-recruitment" class="nav-link active" data-scroll-target="#sec-recruitment"> <span class="header-section-number">12.1</span> Recruitment Methods</a>
  <ul class="collapse">
<li><a href="#study-wide-number-of-subjects" id="toc-study-wide-number-of-subjects" class="nav-link" data-scroll-target="#study-wide-number-of-subjects"> <span class="header-section-number">12.1.1</span> Study-Wide Number of Subjects</a></li>
  <li><a href="#study-wide-recruitment-methods" id="toc-study-wide-recruitment-methods" class="nav-link" data-scroll-target="#study-wide-recruitment-methods"> <span class="header-section-number">12.1.2</span> Study-Wide Recruitment Methods</a></li>
  </ul>
</li>
  <li><a href="#sec-prior-approvals" id="toc-sec-prior-approvals" class="nav-link" data-scroll-target="#sec-prior-approvals"> <span class="header-section-number">12.2</span> Prior Approvals</a></li>
  <li><a href="#sec-recruitment-methods" id="toc-sec-recruitment-methods" class="nav-link" data-scroll-target="#sec-recruitment-methods"> <span class="header-section-number">12.3</span> Recruitment Methods</a></li>
  <li><a href="#sec-consent-process" id="toc-sec-consent-process" class="nav-link" data-scroll-target="#sec-consent-process"> <span class="header-section-number">12.4</span> Consent Process</a></li>
  <li><a href="#sec-document-consent" id="toc-sec-document-consent" class="nav-link" data-scroll-target="#sec-document-consent"> <span class="header-section-number">12.5</span> Process to Document Consent in Writing</a></li>
  <li><a href="#sec-drugs_devices" id="toc-sec-drugs_devices" class="nav-link" data-scroll-target="#sec-drugs_devices"> <span class="header-section-number">12.6</span> Drugs or Devices</a></li>
  </ul><div class="toc-actions"><div><i class="bi bi-github"></i></div><div class="action-links"><p><a href="https://github.com/Goodgolden/scope_dcc/edit/main/26_recruitment.qmd" class="toc-action">Edit this page</a></p><p><a href="https://github.com/Goodgolden/scope_dcc/issues/new" class="toc-action">Report an issue</a></p></div></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content"><header id="title-block-header" class="quarto-title-block default"><div class="quarto-title">
<div class="quarto-title-block"><div><h1 class="title d-none d-lg-block">
<span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Recruitment Methods</span>
</h1><button type="button" class="btn code-tools-button" id="quarto-code-tools-source"><i class="bi"></i> Code</button></div></div>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header><div class="cell">
<style type="text/css">
.scroll-100 {
  max-height: 300px;
  max-width: 1000px;
  overflow-y: auto;
  background-color: inherit;
}
</style>
</div>
<section id="sec-recruitment" class="level2" data-number="12.1"><h2 data-number="12.1" class="anchored" data-anchor-id="sec-recruitment">
<span class="header-section-number">12.1</span> Recruitment Methods</h2>
<section id="study-wide-number-of-subjects" class="level3" data-number="12.1.1"><h3 data-number="12.1.1" class="anchored" data-anchor-id="study-wide-number-of-subjects">
<span class="header-section-number">12.1.1</span> Study-Wide Number of Subjects</h3>
<p>The study sample will include 1150 patients with AML and up to 1150 caregivers. Patients can participate in the study without a caregiver, and we estimate that approximately 50% of patients will have a caregiver participate in the study. Thus, we anticipate the caregiver sample will be approximately 575 participants. Repeated information</p>
</section><section id="study-wide-recruitment-methods" class="level3" data-number="12.1.2"><h3 data-number="12.1.2" class="anchored" data-anchor-id="study-wide-recruitment-methods">
<span class="header-section-number">12.1.2</span> Study-Wide Recruitment Methods</h3>
<p>Prior to the study start, the site investigators will meet with the leukemia clinicians to review recruitment and enrollment procedures.</p>
<p>The CRC will communicate with the leukemia clinicians (the physicians and advanced practice providers who care for the patient in the outpatient setting or during their hospitalization) via email, electronic communication through the health record, or verbally to notify them that the patient is eligible for the study and inquire about concerns regarding their participation. If the clinicians have objections to the patient participation in the study, the CRC will document the reason and not approach those individuals. If the leukemia clinicians have no objections, the CRC will approach patients for study participation within three business days of initiating therapy and inform them that their clinicians have agreed for them to be contacted for the study and review the consent document which details the nature of all study procedures. We have separate consent forms for sites randomized to specialty PC or primary PC. The CRC will obtain written informed consent from the patient and provide them with a copy of the signed consent form.</p>
<p>Study participants will complete baseline self-report assessments at the time of providing informed consent for the study. If a patient signs the consent form but does not complete the baseline assessment within two business days, they will not be registered on the study and will not count towards accrual numbers. To ensure adequate sample size, we will enroll additional participants for any participants who withdraw, or transfer care within the first 30 days of enrollment. We will increase the total accrual goal within each cluster to account for patients who withdraw, or transfer care within 30 days of the study period.</p>
<p>Patients who agree to participate in the study will be asked to identify a caregiver who might be interested in participating. Patients without a willing or interested caregiver will still be eligible to participate in the study. The caregiver will be eligible to enroll in the study either at the same time as the patient or within three business days after the patient provides written informed consent. We have separate consent forms for caregivers at sites randomized to specialty PC or primary PC. Caregivers can enroll in the study in-person with a written informed consent or over the telephone with a verbal consent. Caregivers will complete baseline self-report assessments (in-person, over telephone, or via email) on the same day as providing informed consent or within a one-week window. If a caregiver provides consent but does not complete the baseline assessment, they will not be included as study participants.</p>
<p>Patients and caregivers who speak other languages will have all study procedures and information regarding risks, benefits and study contacts explained to them orally via the use of an interpreter as a first preference or family member as a second preference. Patients who speak other languages will be given the full consent form in their respective language for signing. The consent form will be signed by the participant, and by a witness. The witness will be either an interpreter or a family member. Potentially eligible caregivers will either provide written informed consent or over the telephone with a verbal consent with the assistance of an interpreter (or family member if interpreter is unavailable).</p>
<p>We will also recruit key informants for the qualitative portion of this study. Specifically, we will conduct qualitative interviews stratified by the size of the leukemia program at participating sites. For each key informant group, we will interview 30 individuals, consisting of 10 from each size stratum (small, medium, or large leukemia program). Specifically, we will conduct interviews with:</p>
<ul>
<li><ol type="1">
<li>patients with AML receiving specialty PC and caregivers;</li>
</ol></li>
<li><ol start="2" type="1">
<li>patients with AML receiving primary PC and caregivers;</li>
</ol></li>
<li><ol start="3" type="1">
<li>oncology clinicians;</li>
</ol></li>
<li><ol start="4" type="1">
<li>PC clinicians;</li>
</ol></li>
<li><ol start="5" type="1">
<li>hospital leaders to identify facilitators and barriers to the adoption, implementation, and maintenance of primary PC and specialty PC.</li>
</ol></li>
</ul>
<p>Key informants will provide written or verbal consent over the telephone (given the COVID-19 pandemic).</p>
<p>All study participants (patients, caregivers, and key informants) will be provided a copy of their respective consent forms.</p>
<p><strong>We are requesting a Waiver of Written Documentation of Consent</strong> This Waiver is being requested to assist with caregiver and key informant recruitment during the COVID-19 pandemic. Our study meets the waiver requirements given our study is considered minimal risk and all study procedures could be conveyed orally. This waiver will reduce the risk to caregivers and key informants and is necessary for our research procedures to continue.</p>
<p><strong>We are requesting a HIPAA Waiver of Authorization to Review Preparatory to Research from the IRB.</strong> We are requesting this Waiver to identify potential patient participants from a minimal chart review. In accordance with the DF/HCC policy, this Waiver: - (1) is being sought solely to review Protected Health Information as necessary to prepare a research protocol - (2) will not include removing Protected Health Information from the Covered Entity by the researcher - (3) the Protected Health Information for which we are requesting access is necessary for the research purposes</p>
<p>DF/HCC institutions will register eligible participants in the Clinical Trials Management System (CTMS) Oncore as required by DF/HCC SOP REGIST-101.</p>
<p>For registration of patients from DF/HCC institutions, study staff will complete the protocol-specific eligibility checklist using the eligibility assessment documented in the participant’s medical record and/or research chart. Study staff will confirm that the participant meets all inclusion criteria as described in this protocol and the criteria on the eligibility checklist.</p>
<p>Patients from other investigative sites will be entered on the study centrally by MGH study staff. Study staff from the participating institution will confirm eligibility criteria and fax or email the following documents to study staff at MGH: deidentified signed consent form/s, copy of baseline assessment, and a completed eligibility checklist. MGH study staff will follow DF/HCC Standard Operating Procedure for Human Subject Research Titled Subject Protocol Registration (SOP #: REGIST-101) and register the participant on the protocol. MGH study staff may also call the study staff at the participating site to verbally confirm registration.</p>
</section></section><section id="sec-prior-approvals" class="level2" data-number="12.2"><h2 data-number="12.2" class="anchored" data-anchor-id="sec-prior-approvals">
<span class="header-section-number">12.2</span> Prior Approvals</h2>
<p>The DF/HCC will serve as the single IRB of record for this trial. We will ensure that all participating sites have a reliance agreement to the DF/HCC IRB.</p>
</section><section id="sec-recruitment-methods" class="level2" data-number="12.3"><h2 data-number="12.3" class="anchored" data-anchor-id="sec-recruitment-methods">
<span class="header-section-number">12.3</span> Recruitment Methods</h2>
<p>Please see above for recruitment methods across all study sites. The research staff may provide potentially eligible patients with an informational sheet about the study (Appendix A, Appendix B). Participants will not receive payments for their participation in the study.</p>
</section><section id="sec-consent-process" class="level2" data-number="12.4"><h2 data-number="12.4" class="anchored" data-anchor-id="sec-consent-process">
<span class="header-section-number">12.4</span> Consent Process</h2>
<p>The CRC will obtain written informed consent for patients participating in the study in a private hospital room. Participants will have up to three business days from the initiating of therapy for AML to consent for the study. The CRC will review the consent from with potential participants, which will clearly detail the nature of the study procedures, the time requirements, and the frequency of self-reported assessments. We will have separate consent forms for sites that are randomized to specialty PC or primary PC. The CRC will obtain written informed consent from the participant and provide them with a copy of the signed consent form.</p>
<p>Patients who agree to participate in the study will then be asked to identify a caregiver who might be interested in participating. Patients without a willing or interested caregiver will still be eligible to participate in the study. The caregiver will be eligible to enroll in the study either at the same time as the patient or within three business days after the patient provides written informed consent. We will have a separate consent form for caregivers at sites randomized to specialty PC or primary PC, which will similarly detail the study procedures. Caregivers will have the option of enrolling in the study in-person with a written informed consent or over the telephone with a verbal consent. Patients and/or caregivers who refuse study participation will be asked the reason for deferring. Caregivers will complete baseline self-report assessments on the same day as providing informed consent or within a one-week window. If caregivers provide consent, but do not complete baseline questionnaire, they will not count towards the caregiver accrual numbers.</p>
<p>Patients and caregivers who speak other languages will have all study procedures and information regarding risks, benefits and study contacts explained to them orally via the use of an interpreter as a first preference, or family member as a second preference. Patients who speak other languages will be given the full consent form in their respective language for signing. The consent form will be signed by the participant, and by a witness. The witness will be either an interpreter or a family member. Potentially eligible caregivers will either provide written informed consent or over the telephone with a verbal consent with the assistance of an interpreter (or family member if interpreter is unavailable).</p>
<p>We will also consent key informants for the qualitative portion of this study. Specifically, we will conduct qualitative interviews stratified by the size of the leukemia program at participating sites. For each key informant group, we will interview 30 individuals, consisting of 10 from each size stratum (small, medium, or large leukemia program). Specifically, we will conduct interviews with 1) patients with AML receiving specialty PC and caregivers; 2) patients with AML receiving primary PC and caregivers; 3) oncology clinicians; 4) PC clinicians; and 5) hospital leaders to identify facilitators and barriers to the adoption, implementation, and maintenance of primary PC and specialty PC. Key informants will provide written or verbal consent over the telephone (given COVID-19 pandemic).</p>
</section><section id="sec-document-consent" class="level2" data-number="12.5"><h2 data-number="12.5" class="anchored" data-anchor-id="sec-document-consent">
<span class="header-section-number">12.5</span> Process to Document Consent in Writing</h2>
<p>We will follow all the requirements of SOP: Informed Consent Process (CON-100) in obtaining informed consent for study participants.</p>
<p>All patients participating in the study will provide written informed consent. Caregivers and key informants will have the option of enrolling in the study in-person with a written informed consent or over the telephone with a verbal consent given that the research presents no more than minimal risk of harm</p>
</section><section id="sec-drugs_devices" class="level2" data-number="12.6"><h2 data-number="12.6" class="anchored" data-anchor-id="sec-drugs_devices">
<span class="header-section-number">12.6</span> Drugs or Devices</h2>
<p><mark>Not applicable </mark></p>


<!-- -->

</section></main><!-- /main --><script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  let localAlternateSentinel = 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } 
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  const viewSource = window.document.getElementById('quarto-view-source') ||
                     window.document.getElementById('quarto-code-tools-source');
  if (viewSource) {
    const sourceUrl = viewSource.getAttribute("data-quarto-source-url");
    viewSource.addEventListener("click", function(e) {
      if (sourceUrl) {
        // rstudio viewer pane
        if (/\bcapabilities=\b/.test(window.location)) {
          window.open(sourceUrl);
        } else {
          window.location.href = sourceUrl;
        }
      } else {
        const modal = new bootstrap.Modal(document.getElementById('quarto-embedded-source-code-modal'));
        modal.show();
      }
      return false;
    });
  }
  function toggleCodeHandler(show) {
    return function(e) {
      const detailsSrc = window.document.querySelectorAll(".cell > details > .sourceCode");
      for (let i=0; i<detailsSrc.length; i++) {
        const details = detailsSrc[i].parentElement;
        if (show) {
          details.open = true;
        } else {
          details.removeAttribute("open");
        }
      }
      const cellCodeDivs = window.document.querySelectorAll(".cell > .sourceCode");
      const fromCls = show ? "hidden" : "unhidden";
      const toCls = show ? "unhidden" : "hidden";
      for (let i=0; i<cellCodeDivs.length; i++) {
        const codeDiv = cellCodeDivs[i];
        if (codeDiv.classList.contains(fromCls)) {
          codeDiv.classList.remove(fromCls);
          codeDiv.classList.add(toCls);
        } 
      }
      return false;
    }
  }
  const hideAllCode = window.document.getElementById("quarto-hide-all-code");
  if (hideAllCode) {
    hideAllCode.addEventListener("click", toggleCodeHandler(false));
  }
  const showAllCode = window.document.getElementById("quarto-show-all-code");
  if (showAllCode) {
    showAllCode.addEventListener("click", toggleCodeHandler(true));
  }
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script><nav class="page-navigation"><div class="nav-page nav-page-previous">
      <a href="./25_inclusion_exclusion.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Inclusion Exclusion</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./27_site.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Multi-Site Research</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav><div class="modal fade" id="quarto-embedded-source-code-modal" tabindex="-1" aria-labelledby="quarto-embedded-source-code-modal-label" aria-hidden="true"><div class="modal-dialog modal-dialog-scrollable"><div class="modal-content"><div class="modal-header"><h5 class="modal-title" id="quarto-embedded-source-code-modal-label">Source Code</h5><button class="btn-close" data-bs-dismiss="modal"></button></div><div class="modal-body"><div class="">
<div class="sourceCode" id="cb1" data-shortcodes="false"><pre class="sourceCode markdown code-with-copy"><code class="sourceCode markdown"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="an">title:</span><span class="co"> "Recruitment Methods"</span></span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a><span class="in">```{r setup, include=FALSE}</span></span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a>knitr<span class="sc">::</span>opts_chunk<span class="sc">$</span><span class="fu">set</span>(<span class="at">echo =</span> <span class="cn">TRUE</span>,</span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a>            <span class="at">warnings =</span> <span class="cn">FALSE</span>,</span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a>            <span class="at">message =</span> <span class="cn">FALSE</span>,</span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a>            <span class="at">comment =</span> <span class="st">"#&gt;"</span>,</span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a>            <span class="co">#results = "hide",</span></span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>            <span class="at">digits =</span> <span class="dv">4</span>,</span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a>            <span class="at">error =</span> <span class="cn">FALSE</span>)</span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a><span class="in">```</span></span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a><span class="in">```{css, echo=FALSE}</span></span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a><span class="op">.</span><span class="fu">scroll</span><span class="dv">-100</span> <span class="op">{</span></span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a>  max<span class="op">-</span>height<span class="op">:</span> 300px<span class="op">;</span></span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a>  max<span class="op">-</span>width<span class="op">:</span> 1000px<span class="op">;</span></span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a>  overflow<span class="op">-</span>y<span class="op">:</span> auto<span class="op">;</span></span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a>  background<span class="op">-</span>color<span class="op">:</span> inherit<span class="op">;</span></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a><span class="op">}</span></span>
<span id="cb1-22"><a href="#cb1-22" aria-hidden="true" tabindex="-1"></a><span class="in">```</span></span>
<span id="cb1-23"><a href="#cb1-23" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-24"><a href="#cb1-24" aria-hidden="true" tabindex="-1"></a><span class="fu">## Recruitment Methods {#sec-recruitment}</span></span>
<span id="cb1-25"><a href="#cb1-25" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-26"><a href="#cb1-26" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-27"><a href="#cb1-27" aria-hidden="true" tabindex="-1"></a><span class="fu">### Study-Wide Number of Subjects </span></span>
<span id="cb1-28"><a href="#cb1-28" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-29"><a href="#cb1-29" aria-hidden="true" tabindex="-1"></a>The study sample will include 1150 patients with AML and up to 1150 caregivers.  Patients can participate in the study without a caregiver, and we estimate that approximately 50% of patients will have a caregiver participate in the study. Thus, we anticipate the caregiver sample will be approximately 575 participants. Repeated information</span>
<span id="cb1-30"><a href="#cb1-30" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-31"><a href="#cb1-31" aria-hidden="true" tabindex="-1"></a><span class="fu">### Study-Wide Recruitment Methods</span></span>
<span id="cb1-32"><a href="#cb1-32" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-33"><a href="#cb1-33" aria-hidden="true" tabindex="-1"></a>Prior to the study start, the site investigators will meet with the leukemia clinicians to review recruitment and enrollment procedures.</span>
<span id="cb1-34"><a href="#cb1-34" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-35"><a href="#cb1-35" aria-hidden="true" tabindex="-1"></a>The CRC will communicate with the leukemia clinicians (the physicians and advanced practice providers who care for the patient in the outpatient setting or during their hospitalization) via email, electronic communication through the health record, or verbally to notify them that the patient is eligible for the study and inquire about concerns regarding their participation. If the clinicians have objections to the patient participation in the study, the CRC will document the reason and not approach those individuals. If the leukemia clinicians have no objections, the CRC will approach patients for study participation within three business days of initiating therapy and inform them that their clinicians have agreed for them to be contacted for the study and review the consent document which details the nature of all study procedures. We have separate consent forms for sites randomized to specialty PC or primary PC. The CRC will obtain written informed consent from the patient and provide them with a copy of the signed consent form. </span>
<span id="cb1-36"><a href="#cb1-36" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-37"><a href="#cb1-37" aria-hidden="true" tabindex="-1"></a>Study participants will complete baseline self-report assessments at the time of providing informed consent for the study. If a patient signs the consent form but does not complete the baseline assessment within two business days, they will not be registered on the study and will not count towards accrual numbers. To ensure adequate sample size, we will enroll additional participants for any participants who withdraw, or transfer care within the first 30 days of enrollment. We will increase the total accrual goal within each cluster to account for patients who withdraw, or transfer care within 30 days of the study period.</span>
<span id="cb1-38"><a href="#cb1-38" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-39"><a href="#cb1-39" aria-hidden="true" tabindex="-1"></a>Patients who agree to participate in the study will be asked to identify a caregiver who might be interested in participating. Patients without a willing or interested caregiver will still be eligible to participate in the study. The caregiver will be eligible to enroll in the study either at the same time as the patient or within three business days after the patient provides written informed consent. We have separate consent forms for caregivers at sites randomized to specialty PC or primary PC. Caregivers can enroll in the study in-person with a written informed consent or over the telephone with a verbal consent. Caregivers will complete baseline self-report assessments (in-person, over telephone, or via email) on the same day as providing informed consent or within a one-week window. If a caregiver provides consent but does not complete the baseline assessment, they will not be included as study participants.</span>
<span id="cb1-40"><a href="#cb1-40" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-41"><a href="#cb1-41" aria-hidden="true" tabindex="-1"></a>Patients and caregivers who speak other languages will have all study procedures and information regarding risks, benefits and study contacts explained to them orally via the use of an interpreter as a first preference or family member as a second preference. Patients who speak other languages will be given the full consent form in their respective language for signing. The consent form will be signed by the participant, and by a witness. The witness will be either an interpreter or a family member. Potentially eligible caregivers will either provide written informed consent or over the telephone with a verbal consent with the assistance of an interpreter (or family member if interpreter is unavailable). </span>
<span id="cb1-42"><a href="#cb1-42" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-43"><a href="#cb1-43" aria-hidden="true" tabindex="-1"></a>We will also recruit key informants for the qualitative portion of this study. Specifically, we will conduct qualitative interviews stratified by the size of the leukemia program at participating sites. For each key informant group, we will interview 30 individuals, consisting of 10 from each size stratum (small, medium, or large leukemia program). Specifically, we will conduct interviews with:</span>
<span id="cb1-44"><a href="#cb1-44" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-45"><a href="#cb1-45" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>1) patients with AML receiving specialty PC and caregivers; </span>
<span id="cb1-46"><a href="#cb1-46" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>2) patients with AML receiving primary PC and caregivers; </span>
<span id="cb1-47"><a href="#cb1-47" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>3) oncology clinicians; </span>
<span id="cb1-48"><a href="#cb1-48" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>4) PC clinicians; </span>
<span id="cb1-49"><a href="#cb1-49" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>5) hospital leaders to identify facilitators and barriers to the adoption, implementation, and maintenance of primary PC and specialty PC. </span>
<span id="cb1-50"><a href="#cb1-50" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-51"><a href="#cb1-51" aria-hidden="true" tabindex="-1"></a>Key informants will provide written or verbal consent over the telephone (given the COVID-19 pandemic).</span>
<span id="cb1-52"><a href="#cb1-52" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-53"><a href="#cb1-53" aria-hidden="true" tabindex="-1"></a>All study participants (patients, caregivers, and key informants) will be provided a copy of their respective consent forms.</span>
<span id="cb1-54"><a href="#cb1-54" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-55"><a href="#cb1-55" aria-hidden="true" tabindex="-1"></a>**We are requesting a Waiver of Written Documentation of Consent**</span>
<span id="cb1-56"><a href="#cb1-56" aria-hidden="true" tabindex="-1"></a>This Waiver is being requested to assist with caregiver and key informant recruitment during the COVID-19 pandemic. Our study meets the waiver requirements given our study is considered minimal risk and all study procedures could be conveyed orally. This waiver will reduce the risk to caregivers and key informants and is necessary for our research procedures to continue. </span>
<span id="cb1-57"><a href="#cb1-57" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-58"><a href="#cb1-58" aria-hidden="true" tabindex="-1"></a>**We are requesting a HIPAA Waiver of Authorization to Review Preparatory to Research from the IRB.**</span>
<span id="cb1-59"><a href="#cb1-59" aria-hidden="true" tabindex="-1"></a>We are requesting this Waiver to identify potential patient participants from a minimal chart review. In accordance with the DF/HCC policy, this Waiver: </span>
<span id="cb1-60"><a href="#cb1-60" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>(1) is being sought solely to review Protected Health Information as necessary to prepare a research protocol</span>
<span id="cb1-61"><a href="#cb1-61" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>(2) will not include removing Protected Health Information from the Covered Entity by the researcher</span>
<span id="cb1-62"><a href="#cb1-62" aria-hidden="true" tabindex="-1"></a><span class="ss">- </span>(3) the Protected Health Information for which we are requesting access is necessary for the research purposes</span>
<span id="cb1-63"><a href="#cb1-63" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-64"><a href="#cb1-64" aria-hidden="true" tabindex="-1"></a>DF/HCC institutions will register eligible participants in the Clinical Trials Management System (CTMS) Oncore as required by DF/HCC SOP REGIST-101. </span>
<span id="cb1-65"><a href="#cb1-65" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-66"><a href="#cb1-66" aria-hidden="true" tabindex="-1"></a>For registration of patients from DF/HCC institutions, study staff will complete the protocol-specific eligibility checklist using the eligibility assessment documented in the participant’s medical record and/or research chart. Study staff will confirm that the participant meets all inclusion criteria as described in this protocol and the criteria on the eligibility checklist. </span>
<span id="cb1-67"><a href="#cb1-67" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-68"><a href="#cb1-68" aria-hidden="true" tabindex="-1"></a>Patients from other investigative sites will be entered on the study centrally by MGH study staff. Study staff from the participating institution will confirm eligibility criteria and fax or email the following documents to study staff at MGH: deidentified signed consent form/s, copy of baseline assessment, and a completed eligibility checklist. MGH study staff will follow DF/HCC Standard Operating Procedure for Human Subject Research Titled Subject Protocol Registration (SOP #: REGIST-101) and register the participant on the protocol. MGH study staff may also call the study staff at the participating site to verbally confirm registration.</span>
<span id="cb1-69"><a href="#cb1-69" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-70"><a href="#cb1-70" aria-hidden="true" tabindex="-1"></a><span class="fu">## Prior Approvals {#sec-prior-approvals}</span></span>
<span id="cb1-71"><a href="#cb1-71" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-72"><a href="#cb1-72" aria-hidden="true" tabindex="-1"></a>The DF/HCC will serve as the single IRB of record for this trial. We will ensure that all participating sites have a reliance agreement to the DF/HCC IRB.</span>
<span id="cb1-73"><a href="#cb1-73" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-74"><a href="#cb1-74" aria-hidden="true" tabindex="-1"></a><span class="fu">## Recruitment Methods {#sec-recruitment-methods}</span></span>
<span id="cb1-75"><a href="#cb1-75" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-76"><a href="#cb1-76" aria-hidden="true" tabindex="-1"></a>Please see above for recruitment methods across all study sites. The research staff may provide potentially eligible patients with an informational sheet about the study (Appendix A, Appendix B). Participants will not receive payments for their participation in the study. </span>
<span id="cb1-77"><a href="#cb1-77" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-78"><a href="#cb1-78" aria-hidden="true" tabindex="-1"></a><span class="fu">## Consent Process {#sec-consent-process}</span></span>
<span id="cb1-79"><a href="#cb1-79" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-80"><a href="#cb1-80" aria-hidden="true" tabindex="-1"></a>The CRC will obtain written informed consent for patients participating in the study in a private hospital room. Participants will have up to three business days from the initiating of therapy for AML to consent for the study. The CRC will review the consent from with potential participants, which will clearly detail the nature of the study procedures, the time requirements, and the frequency of self-reported assessments. We will have separate consent forms for sites that are randomized to specialty PC or primary PC. The CRC will obtain written informed consent from the participant and provide them with a copy of the signed consent form.</span>
<span id="cb1-81"><a href="#cb1-81" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-82"><a href="#cb1-82" aria-hidden="true" tabindex="-1"></a>Patients who agree to participate in the study will then be asked to identify a caregiver who might be interested in participating. Patients without a willing or interested caregiver will still be eligible to participate in the study. The caregiver will be eligible to enroll in the study either at the same time as the patient or within three business days after the patient provides written informed consent. We will have a separate consent form for caregivers at sites randomized to specialty PC or primary PC, which will similarly detail the study procedures. Caregivers will have the option of enrolling in the study in-person with a written informed consent or over the telephone with a verbal consent. Patients and/or caregivers who refuse study participation will be asked the reason for deferring. Caregivers will complete baseline self-report assessments on the same day as providing informed consent or within a one-week window. If caregivers provide consent, but do not complete baseline questionnaire, they will not count towards the caregiver accrual numbers.</span>
<span id="cb1-83"><a href="#cb1-83" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-84"><a href="#cb1-84" aria-hidden="true" tabindex="-1"></a>Patients and caregivers who speak other languages will have all study procedures and information regarding risks, benefits and study contacts explained to them orally via the use of an interpreter as a first preference, or family member as a second preference. Patients who speak other languages will be given the full consent form in their respective language for signing. The consent form will be signed by the participant, and by a witness. The witness will be either an interpreter or a family member. Potentially eligible caregivers will either provide written informed consent or over the telephone with a verbal consent with the assistance of an interpreter (or family member if interpreter is unavailable). </span>
<span id="cb1-85"><a href="#cb1-85" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-86"><a href="#cb1-86" aria-hidden="true" tabindex="-1"></a>We will also consent key informants for the qualitative portion of this study. Specifically, we will conduct qualitative interviews stratified by the size of the leukemia program at participating sites. For each key informant group, we will interview 30 individuals, consisting of 10 from each size stratum (small, medium, or large leukemia program). Specifically, we will conduct interviews with 1) patients with AML receiving specialty PC and caregivers; 2) patients with AML receiving primary PC and caregivers; 3) oncology clinicians; 4) PC clinicians; and 5) hospital leaders to identify facilitators and barriers to the adoption, implementation, and maintenance of primary PC and specialty PC. Key informants will provide written or verbal consent over the telephone (given COVID-19 pandemic).</span>
<span id="cb1-87"><a href="#cb1-87" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-88"><a href="#cb1-88" aria-hidden="true" tabindex="-1"></a><span class="fu">## Process to Document Consent in Writing {#sec-document-consent}</span></span>
<span id="cb1-89"><a href="#cb1-89" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-90"><a href="#cb1-90" aria-hidden="true" tabindex="-1"></a>We will follow all the requirements of SOP: Informed Consent Process (CON-100) in obtaining informed consent for study participants.</span>
<span id="cb1-91"><a href="#cb1-91" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-92"><a href="#cb1-92" aria-hidden="true" tabindex="-1"></a>All patients participating in the study will provide written informed consent. Caregivers and key informants will have the option of enrolling in the study in-person with a written informed consent or over the telephone with a verbal consent given that the research presents no more than minimal risk of harm</span>
<span id="cb1-93"><a href="#cb1-93" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-94"><a href="#cb1-94" aria-hidden="true" tabindex="-1"></a><span class="fu">## Drugs or Devices {#sec-drugs_devices}</span></span>
<span id="cb1-95"><a href="#cb1-95" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-96"><a href="#cb1-96" aria-hidden="true" tabindex="-1"></a><span class="kw">&lt;mark&gt;</span>Not applicable <span class="kw">&lt;/mark&gt;</span></span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
</div></div></div></div></div>
</div> <!-- /content -->
<footer class="footer"><div class="nav-footer">
    <div class="nav-footer-left">This Analytic Plan was written by Randy.</div>   
    <div class="nav-footer-right">This book was built with <a href="https://quarto.org/">Quarto</a>.</div>
  </div>
</footer>


</body></html>